Blackrock Neurotech, a Salt Lake City, UT-based brain-computer-interface (BCI) technology company, received a $200M investment from Tether.
The company intends to use the funds for the commercialization and roll-out of its medical solutions that have already been applied to more than 40 individuals, and to further boost its R&D efforts.
Founded in 2008 by Dr. Florian Solzbacher and Marcus Gerhardt, Blackrock Neurotech is a human BCI company whose mission is to help the millions of people around the world afflicted with paralysis, lost function and neurological disorders that prevent them from walking, seeing, hearing, feeling, or talking. Its precision electrode technology is at the core of many worldwide innovations in BCI, enabling early users to see, hear, feel and move again. In addition, Blackrock produces advanced platform tools for neuroscience, neural engineering and neuroprosthetics, empowering pioneering research at more than 500 leading institutions worldwide.
Commenting on the news, Florian Solzbacher said: “My life’s dream has been to help and restore function in people who lost it and to advance technologies that revolutionize healthcare and the world around us. This ambitious, long-term endeavor requires dedicated and visionary partners. With its commitment to seeking out and nurturing technology that will help many people and push mankind forward, we couldn’t dream of a better partner than Tether to bring our shared vision to life.”
FinSMEs
30/04/2024